Meet the Investors: Kairos Ventures
to
COVID-19 Basic Research
To add your information, please fill out this form.
Please look here for a list of potential COVID-19 Collaborators by Area of Expertise.
Omid Akbari
Pedram S Jahani
Georges Helou
Characterized the lung immune cells for COVID-19 and are now measuring human serum to establish immunity.
Omid Akbari
Study the immune landscape of patients with COVID-19.
Houda Alachkar
Serghei Mangul
Bassam Yaghmour
George Yaghmour
Emi Minejima
Annie Wong-Beringer
Study of T Cell Repertoire Changes in SARS-COV-2 (COVID-19) Infected Subjects
Alexandre Bonnin
Thea Tagliaferro
Qiuying Zhao
Saloni Walia
Sue Martin
Effects of maternal COVID-19 infection on blood placenta barrier integrity.
Michael Bowdish
Zea Borok
Adupa P Rao
Perren Cobb
Meghan Lewis
John Alexander-Dam
Studying stem cells and exosomes for moderate-severe COVID-19 respiratory distress syndrome.
Paula Cannon
Providing non-infectious models of viral entry into cells for antibody screening.
Vadim Cherezov
Structural basis of SARS-CoV-2 entry in the host cell
Edward Crandall
Kwang Jin Kim
Arnold Sipos
Wei Ming Yuan
Studying exposure to COVID-19 proteins on lung cell function.
Stephen Cronin
Pin Wang
Deactivation of Airborne and Surface-Borne Viruses using Nanosecond Pulsed Plasmas
Francesco Cutrale
Mapping SARS-CoV-2-induced metabolic changes in lung alveolar epithelial cells and macrophages
Senta Georgia
Understanding the role of COVID19 in insulin cell dysfunction and the pathogenesis of diabetes
Young-Kwon Hong
Dongwon Choi
Identifying and characterizing how COVID-19 enters human host cells.
Young-Kwon Hong
CEACAM proteins as New Cellular Receptors for SARS-Cov-2
Jae U Jung
Clinical outcomes, viral shedding and development of immune responses in mother-infant pairs affected by COVID-19.
Catherine Kuza
J. Perren Cobb
Aarya Kafi
Keith Killu
Santhi Kumar
May Lee
Phillip Lumb
Peter Marshall
Adupa Rao
Mandeep Singh
Albert Yen
Samantha Huang
Spencer Roberson
Julian Wier
Donald Solio
Kimberly Sinclair
Delirium in critically ill patients with SARS-CoV-2 infection.
Hayoun Lee
Adapting sequence-based HIV platform for phylogenetic analysis of COVID-19 virus.
Hayoun Lee
SARS-CoV-2 whole genome sequencing and transmission cluster identification for COVID-19 genomic surveillance
Chengyu Liang
Studying mechanisms of virus entry and egress to identify new methods for virus prevention via blocking transmission.
Keigo Machida
Studying inhibition of COVID virus receptors for drug treatments.
Suraiya Rasheed
Zea Borok
Identification of specific COVID-19 mutations at different stages of lung disease.
Suraiya Rasheed
William Guaderman
Eric Kawaguchi
Neha Nanda
Classification of COVID-19 viral genome sequences in relation to disease severity.
Sita Reddy
Lucio Comai
Developed a pipeline to monitor genome-wide translation in live cells to, aiding the study of interactions between the virus and its human host.
Richard Roberts
Terry Takahashi
Constructing SARS virus proteins, developing high affinity binding reagents to these proteins, and deploying these reagents in serological assays to measure both viral proteins in biological fluids and the host antibody responses to infections. More here and here.
Bodour Salhia
Parkash Gill
Heinz-Josef Lenz
Ann Hamilton
Juan Pablo Lewinger
Identifying molecular markers of severe outcome susceptibility for COVID-19.
Satish Thittamaranahalli
Rajiv Kalia
Data-Driven Modeling of Viral Dynamics in Covid-19 Patients
Marc Vermulst
RAPID: Probing SARS-CoV-2 evolution and vulnerabilities through its mutation and fitness landscape
Annie Wong-Beringer
Emi Minejima
Corey Kelsom
Studying secondary bacterial infections in patients hospitalized for COVID-19.
Weiming Yuan
Identifying SARS-CoV-2 virus genes responsible for disregulating human immune responses.
Weiming Yuan
Suppression of NKT cell function by SARS-CoV-2 virus
Chao Zhang
Discovering inhibitors of coronavirus protein.
Chao Zhang
Arieh Warshel
Pinghui Feng
Efficient Antiviral Discovery via Covalently Targeting SARS-CoV-2 Main Protease